ÂÜÀòÂÒÂ×

Eran Broshy is an accomplished, strategically focused board director and private equity operating executive working broadly across the healthcare space, with a demonstrated 35+ year track record of building high-growth public and private healthcare businesses. He served for over a decade as the chief executive officer and chairman of inVentiv Health, Inc. (now part of Syneos), and previously was a management consultant with The Boston Consulting Group and the partner responsible for BCG’s healthcare practice across the Americas.

Mr. Broshy has served on multiple private and public healthcare company boards, and he currently serves on the board of directors of Theravance Biopharma and of Thirty Madison. He is also a member of the Corporation of the Massachusetts Institute of Technology (MIT’s governing body), as chairman of the American Friends of the Open University of Israel, and on the board of governors of the American Jewish Committee.

Mr. Broshy holds an M.B.A. from Harvard University, an M.S. in civil engineering from Stanford University, and a B.S. in civil engineering from the Massachusetts Institute of Technology.